Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
Condition: Hematological Malignancy Intervention: Genetic: Genetically engineered NK cells Sponsor: Fate Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials